Table 2.
Annual seroprevalence of HIV, HBV, HCV and syphilis among Koula-Moutou’s blood donors from 2012 to 2017
| Year | Total | VIH +N(%) | VHC + N(%) | VHB + N(%) | Syphilis + N(%) |
|---|---|---|---|---|---|
| 2012 | 771 | 29(3.8) | 50(6.5) | 52(6.7) | 30(3.9) |
| 2013 | 864 | 30(3.5) | 62(7.2) | 64(7.4) | 21(2.4) |
| 2014 | 1292 | 23(1.8) | 97(7.5) | 78(6.0) | 27(2.1) |
| 2015 | 546 | 13(2.4) | 28(5.1) | 32(5.9) | 18(3.3) |
| 2016 | 1205 | 41(3.4) | 84(7.0) | 64(5.3) | 36(3.0) |
| 2017 | 1028 | 40(3.9) | 30(2.9) | 48(4.7) | 57(5.5) |
| Total | 5706 | 176(3.1) | 351(6.2) | 338(5.9) | 189(3.3) |
| P-value | - | 0.028 | 0.001 | 0.151 | 0.001 |